Many primary aldosteronism cases remain undiagnosed and untreated Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today. “Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline” was published online and is being presented at ENDO 2025, the...
Scientific Statement aims to expand our research to advance the understanding of the cause and progression of type 1 diabetes. A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes that should help with the development of new and improved treatment options. ...
Starting in January 2026, the masthead of the Endocrine Society’s flagship basic science journal Endocrinology will have a new name at the top: Manuel Tena-Sempere, MD, PhD. He speaks to Endocrine News about his new role, how the journal has impacted his own research career, and how he plans to make the journal more appealing...
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States v. Skrmetti decision, which increases the likelihood that other states will limit or eliminate families’ and patients’ ability to access medical care. As doctors, nurse practitioners, and nurses, we believe that every patient is different. Decisions...
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval before...
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than...
“Cosmic Bubble” image features cells from a thyroid cancer subtype Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”. The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...
The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne...
Starting in January 2026, the masthead of the Endocrine Society’s flagship basic science journal Endocrinology will have a new name at the top: Manuel Tena-Sempere, MD, PhD. He speaks to Endocrine News about his new role, how the journal has impacted his own research career, and how he plans to make the journal more appealing...
“Cosmic Bubble” image features cells from a thyroid cancer subtype Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”. The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...
